• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用双标记技术检测石蜡包埋组织中P53表达和S期细胞分数。

Detection of P53 expression and S-phase cell fraction in paraffin-embedded tissue by a double-labeling technique.

作者信息

Benini E, Silvestrini R, Daidone M G, Canova S

机构信息

Istituto Nazionale per lo Studio e la Cura dei Tumori, Oncologia Sperimentale C, Milano, Italia.

出版信息

J Histochem Cytochem. 1995 Oct;43(10):999-1003. doi: 10.1177/43.10.7560890.

DOI:10.1177/43.10.7560890
PMID:7560890
Abstract

TP53 is a gene that normally regulates cell growth and division. Alterations to it may induce a proliferative advantage and confer an aggressive phenotype. In breast cancer, we observed a poor correlation (rs = 0.17) between P53 expression and proliferative activity evaluated as [3H]-thymidine ([3H]-dT) labeling index and an independent prognostic relevance of the two variables. We used a double-labeling technique to simultaneously evaluate the fraction of P53-positive and [3H]-dT-labeled cells to analyze the degree of association between the two markers on individual cells in order to understand their biological significance. The study was performed on a series of 44 P53-positive (P53+) breast cancers. Histological sections were immunostained for P53 with monoclonal antibody (MAb) PAb1801 and then processed for autoradiography. A weak direct relation between P53 positivity and [3H]-dT incorporation (rs = 0.4) was observed on the overall series of P53+ tumors and was maintained in subgroups defined by several biological and pathological features, except for estrogen receptor-negative tumors. The simultaneous presence of P53 expression and [3H]-dT incorporation was directly and significantly proportional to the fraction of S-phase cells of the tumor (rs = 0.7). Conversely, the fraction of cells expressing only P53 was inversely related to cell proliferation (rs = -0.66). These findings support the hypothesis that P53 has biological functions other than cell cycle regulation.

摘要

TP53是一种正常情况下调节细胞生长和分裂的基因。其改变可能会诱导增殖优势并赋予侵袭性表型。在乳腺癌中,我们观察到P53表达与以[3H] - 胸腺嘧啶核苷([3H] - dT)标记指数评估的增殖活性之间存在较差的相关性(rs = 0.17),并且这两个变量具有独立的预后相关性。我们使用双标记技术同时评估P53阳性细胞和[3H] - dT标记细胞的比例,以分析单个细胞上这两种标记之间的关联程度,从而了解它们的生物学意义。该研究对一系列44例P53阳性(P53 +)乳腺癌进行。组织学切片用单克隆抗体(MAb)PAb1801对P53进行免疫染色,然后进行放射自显影处理。在整个P53 +肿瘤系列中观察到P53阳性与[3H] - dT掺入之间存在弱的直接关系(rs = 0.4),并且在由几种生物学和病理学特征定义的亚组中保持这种关系,但雌激素受体阴性肿瘤除外。P53表达和[3H] - dT掺入的同时存在与肿瘤S期细胞的比例直接且显著相关(rs = 0.7)。相反,仅表达P53的细胞比例与细胞增殖呈负相关(rs = -0.66)。这些发现支持了P53除了细胞周期调节之外还具有其他生物学功能的假设。

相似文献

1
Detection of P53 expression and S-phase cell fraction in paraffin-embedded tissue by a double-labeling technique.采用双标记技术检测石蜡包埋组织中P53表达和S期细胞分数。
J Histochem Cytochem. 1995 Oct;43(10):999-1003. doi: 10.1177/43.10.7560890.
2
p53 as an independent prognostic marker in lymph node-negative breast cancer patients.p53作为淋巴结阴性乳腺癌患者的独立预后标志物。
J Natl Cancer Inst. 1993 Jun 16;85(12):965-70. doi: 10.1093/jnci/85.12.965.
3
Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.肿瘤抑制蛋白p53过表达与淋巴结阴性乳腺癌患者细胞快速增殖及预后不良的相关性
J Natl Cancer Inst. 1992 Jul 15;84(14):1109-14. doi: 10.1093/jnci/84.14.1109.
4
The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients.Bcl-2蛋白:一种与淋巴结阴性乳腺癌患者中p53蛋白密切相关的预后指标。
J Natl Cancer Inst. 1994 Apr 6;86(7):499-504. doi: 10.1093/jnci/86.7.499.
5
p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.乳腺癌中p53和c-erbB-2蛋白表达。一项免疫组织化学研究,包括与人类乳腺癌受体状态、增殖标志物及临床分期的相关性。
Am J Clin Pathol. 1992 Oct;98(4):408-18. doi: 10.1093/ajcp/98.4.408.
6
Changes in biological markers after primary chemotherapy for breast cancers.
Int J Cancer. 1995 May 4;61(3):301-5. doi: 10.1002/ijc.2910610304.
7
Prognostic significance of proliferative activity and ploidy in node-negative breast cancers.淋巴结阴性乳腺癌中增殖活性和倍性的预后意义
Ann Oncol. 1993 Mar;4(3):213-9. doi: 10.1093/oxfordjournals.annonc.a058458.
8
Validation of p53 accumulation as a predictor of distant metastasis at 10 years of follow-up in 1400 node-negative breast cancers.
Clin Cancer Res. 1996 Dec;2(12):2007-13.
9
MIB1 proliferation index in breast infiltrating carcinoma: comparison with other proliferative markers and association with new biological prognostic factors.乳腺浸润性癌中的MIB1增殖指数:与其他增殖标志物的比较及与新生物预后因素的关联
Histol Histopathol. 2001 Apr;16(2):399-406. doi: 10.14670/HH-16.399.
10
High proliferative rates demonstrated by bromodeoxyuridine labeling index in breast carcinomas with p53 overexpression.在p53过表达的乳腺癌中,溴脱氧尿苷标记指数显示出高增殖率。
J Surg Oncol. 1994 Jul;56(3):146-52. doi: 10.1002/jso.2930560304.